A Study of Milvexian in Healthy Adult Females
Clinical trial NCT05706753 · COMPLETED
Trial details
- NCT number
- NCT05706753
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-25
- Primary completion
- 2023-07-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.